Literature DB >> 34105999

Low-Density Lipoprotein Receptor Suppresses the Endogenous Cholesterol Synthesis Pathway To Oppose Gammaherpesvirus Replication in Primary Macrophages.

C A Aurubin1, D A Knaack2,3, D Sahoo2,4,3,5, V L Tarakanova1,5.   

Abstract

Gammaherpesviruses are ubiquitous pathogens that establish lifelong infections in >95% of adults worldwide and are associated with several cancers. We have shown that endogenous cholesterol synthesis supports gammaherpesvirus replication. However, the role of exogenous cholesterol exchange and signaling during infection remains poorly understood. Extracellular cholesterol is carried in the serum by several lipoproteins, including low-density lipoproteins (LDL). The LDL receptor (LDL-R) mediates the endocytosis of these cholesterol-rich LDL particles into the cell, thereby supplying the cell with cholesterol. We found that LDL-R expression attenuates gammaherpesvirus replication during the early stages of the replication cycle, as evident by increased viral gene expression in LDL-R-/- primary macrophages. This was not observed in primary fibroblasts, indicating that the antiviral effects of LDL-R are cell type specific. Increased viral gene expression in LDL-R-/- primary macrophages was due to increased activity of the endogenous cholesterol synthesis pathway. Intriguingly, despite type I interferon-driven increase in LDL-R mRNA levels in infected macrophages, protein levels of LDL-R continually decreased over the single cycle of viral replication. Thus, our study has uncovered an intriguing tug of war between the LDL-R-driven antiviral effect on cholesterol metabolism and the viral targeting of the LDL-R protein. IMPORTANCE LDL-R is a cell surface receptor that mediates the endocytosis of cholesterol-rich low-density lipoproteins, allowing cells to acquire cholesterol exogenously. Several RNA viruses usurp LDL-R function to facilitate replication; however, the role of LDL-R in DNA virus infection remains unknown. Gammaherpesviruses are double-stranded DNA viruses that are associated with several cancers. Here, we show that LDL-R attenuates gammaherpesvirus replication in primary macrophages by decreasing endogenous cholesterol synthesis activity, a pathway known to support gammaherpesvirus replication. In response, LDL-R protein levels are decreased in infected cells to mitigate the antiviral effects, revealing an intriguing tug of war between the virus and the host.

Entities:  

Keywords:  LDL receptor; cholesterol; gammaherpesvirus; interferons; lytic replication

Mesh:

Substances:

Year:  2021        PMID: 34105999      PMCID: PMC8354329          DOI: 10.1128/JVI.00649-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage.

Authors:  M Shimakage; M Kimura; S Yanoma; M Ibe; S Yokota; G Tsujino; T Kozuka; T Dezawa; S Tamura; A Ohshima; M Yutsudo; A Hakura
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells.

Authors:  Kenrie P Y Hui; Denise I T Kuok; Sara S R Kang; Hung-Sing Li; Mandy M T Ng; Christine H T Bui; J S Malik Peiris; Renee W Y Chan; Michael C W Chan
Journal:  Antiviral Res       Date:  2015-04-13       Impact factor: 5.970

3.  Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri.

Authors:  S Efstathiou; Y M Ho; S Hall; C J Styles; S D Scott; U A Gompels
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

4.  Coordinate regulation of DNA damage and type I interferon responses imposes an antiviral state that attenuates mouse gammaherpesvirus type 68 replication in primary macrophages.

Authors:  Wadzanai P Mboko; Bryan C Mounce; Brittani M Wood; Joseph M Kulinski; John A Corbett; Vera L Tarakanova
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

Review 5.  Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.

Authors:  Francesco Negro; Arun J Sanyal
Journal:  Liver Int       Date:  2009-03       Impact factor: 5.828

6.  Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50.

Authors:  Megan M Goodwin; Susan Canny; Ashley Steed; Herbert W Virgin
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

7.  MHV68 complement regulatory protein facilitates MHV68 replication in primary macrophages in a complement independent manner.

Authors:  Vera L Tarakanova; Jerome M Molleston; Megan Goodwin; Herbert W Virgin
Journal:  Virology       Date:  2009-11-11       Impact factor: 3.616

8.  Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.

Authors:  Nicolas Ponroy; Aline Taveira; Nicolas J Mueller; Anne-Laure Millard
Journal:  J Med Virol       Date:  2014-06-27       Impact factor: 2.327

9.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

10.  Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics.

Authors:  Deborah L Diamond; Andrew J Syder; Jon M Jacobs; Christina M Sorensen; Kathie-Anne Walters; Sean C Proll; Jason E McDermott; Marina A Gritsenko; Qibin Zhang; Rui Zhao; Thomas O Metz; David G Camp; Katrina M Waters; Richard D Smith; Charles M Rice; Michael G Katze
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more
  2 in total

1.  The Hypolipidemic Effect of Dalbergia odorifera T. C. Chen Leaf Extract on Hyperlipidemic Rats and Its Mechanism Investigation Based on Network Pharmacology.

Authors:  Hui Mei; Huiming Hu; Yanni Lv; Guangqiang Ma; Fangrui Tang; Zhou Hong; Feng Shao
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-27       Impact factor: 2.629

2.  Cholesterol Biosynthesis Modulates CSFV Replication.

Authors:  Xiaodong Zou; Feng Lin; Yang Yang; Jiahuan Chen; Huanyu Zhang; Linquan Li; Hongsheng Ouyang; Daxin Pang; Xiaochun Tang
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.